A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units
Candida spp. are the fourth on the list of sepsis pathogens in patients in intensive care units. Currently the physician’s armamentarium includes a whole range of antifungal medicines that have demonstrated high clinicalmycological effectiveness in clinical trials. The aim of this study to evaluate...
Main Authors: | A. S. Kolbin, O. A. Koroleva, N. N. Klimko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2014-09-01
|
Series: | Žurnal Infektologii |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/284 |
Similar Items
-
Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit
by: Arslankoylu Ali Ertug, et al.
Published: (2011-11-01) -
Invasive candidiasis in children
by: N. N. Klimko, et al.
Published: (2021-07-01) -
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
by: Matteo Bassetti, et al.
Published: (2019-06-01) -
Criteria for the administration of systemic antimicotic therapy in surgical intensive care units (literature review)
by: B. Z. Belotserkovskiy, et al.
Published: (2019-11-01) -
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant – non-neutropenic adult ICU patients
by: Sébastien Bailly, et al.
Published: (2017-01-01)